Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Oct;52(10):2468–2485. doi: 10.1172/JCI107438

The Kinetics of Intramolecular Distribution of 15N in Uric Acid after Administration of [15N]Glycine A REAPPRAISAL OF THE SIGNIFICANCE OF PREFERENTIAL LABELING OF N-(3 + 9) OF URIC ACID IN PRIMARY GOUT

Oded Sperling 1,2, James B Wyngaarden 1,2, C Frank Starmer 1,2
PMCID: PMC302506  PMID: 4353999

Abstract

The concept of an abnormality of glutamine metabolism in primary gout was first proposed on the basis of isotope data: when [15N]glycine was administered to gouty subjects, there was disproportionately great enrichment of N-(3 + 9) of uric acid, which derive from the amide-N of glutamine. An unduly high concentration of 15N in glutamine was postulated, and attributed to a hypothetical defect in catabolism of glutamine. Excess glutamine was proposed as the driving force of uric acid overproduction.

We have reexamined this proposition in four gouty subjects: one mild overproducer of uric acid with “idiopathic gout,” one marked overproducer with high-grade but “partial” hypoxanthine-guanine phosphoribosyl-transferase deficiency, and two extraordinary overproducers with superactive phosphoribosylpyrophosphate synthetases. In the last three, the driving force of excessive purine biosynthesis is a known surplus of α-5-phosphoribosyl-1-pyrophosphate. Disproportionately high labeling of N-(3 + 9) was present in all four gouty subjects, most marked in the most flamboyant overproducers. The precursor glucine pool was sampled by periodic administration of benzoic acid and isolation of urinary hippuric acid. Similarly, the precursor glutamine pool was sampled by periodic administration of phenylacetic acid and isolation of the amide-N of urinary phenylacetylglutamine. The time course of 15N enrichment of hippurate differed from that of the amide-N of glutamine. Whereas initial enrichment values of hippurate were very high, those of glutamine-amide-N were low, increasing to a maximum at about 3 h, and then declining less rapidly than those of hippurate. However, enrichment values of hippurate and of phenacetyl glutamine were normal in all of the gouty subjects studied. Thus, preferential enrichment of N-(3 + 9) in gouty overproducers given [15N]glycine does not necessarily reflect a specific abnormality of glutamine metabolism, but rather appears to be a kinetic phenomenon associated with accelerated purine biosynthesis per se.

In addition, greater enrichment of N-9 than of N-3 on days 1 and 2 provided suggestive evidence for a second pathway for synthesis of the initial precursor of purine biosynthesis, phosphoribosylamine, perhaps utilizing ammonia rather than the amide-N of glutamine as nitrogen donor. In this limited study, the activity of this potential second pathway did not appear to be selectively increased in gout.

Full text

PDF
2468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARZEL U. S., SPERLING O., FRANK M., DEVRIES A. RENAL AMMONIUM EXCRETION AND URINARY PH IN IDIOPATHIC URIC ACID LITHIASIS. J Urol. 1964 Jul;92:1–5. doi: 10.1016/S0022-5347(17)63875-8. [DOI] [PubMed] [Google Scholar]
  2. BENEDICT J. D., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J Clin Invest. 1953 Aug;32(8):775–777. doi: 10.1172/JCI102791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRANDENBERGER H. The oxidation of uric acid to oxonic acid (allantoxanic acid) and its application in tracer studies of uric acid biosynthesis. Biochim Biophys Acta. 1954 Sep;15(1):108–116. doi: 10.1016/0006-3002(54)90099-2. [DOI] [PubMed] [Google Scholar]
  4. Becker M. A., Meyer L. J., Wood A. W., Seegmiller J. E. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science. 1973 Mar 16;179(4078):1123–1126. doi: 10.1126/science.179.4078.1123. [DOI] [PubMed] [Google Scholar]
  5. CASKEY C. T., ASHTON D. M., WYNGAARDEN J. B. THE ENZYMOLOGY OF FEEDBACK INHIBITION OF GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE BY PURINE RIBONUCLEOTIDES. J Biol Chem. 1964 Aug;239:2570–2579. [PubMed] [Google Scholar]
  6. Carcassi A., Marcolongo R., Jr, Marinello E., Riario-Sforza G., Boggiano C. Liver xanthine oxidase in gouty patients. Arthritis Rheum. 1969 Feb;12(1):17–20. doi: 10.1002/art.1780120104. [DOI] [PubMed] [Google Scholar]
  7. Emmerson B. T., Wyngaarden J. B. Purine metabolism in heterozygous carriers of hypoxanthine-guanine phosphoribosyltransferase deficiency. Science. 1969 Dec 19;166(3912):1533–1535. doi: 10.1126/science.166.3912.1533. [DOI] [PubMed] [Google Scholar]
  8. FRIEDEN C. GLUTAMATE DEHYDROGENASE. V. THE RELATION OF ENZYME STRUCTURE TO THE CATALYTIC FUNCTION. J Biol Chem. 1963 Oct;238:3286–3299. [PubMed] [Google Scholar]
  9. Fox I. H., Kelley W. N. Phosphoribosylpyrophosphate in man: biochemical and clinical significance. Ann Intern Med. 1971 Mar;74(3):424–433. doi: 10.7326/0003-4819-74-3-424. [DOI] [PubMed] [Google Scholar]
  10. Fox I. H., Wyngaarden J. B., Kelley W. N. Depletion of erythrocyte phosphoribosylpyrophosphate in man. N Engl J Med. 1970 Nov 26;283(22):1177–1182. doi: 10.1056/NEJM197011262832201. [DOI] [PubMed] [Google Scholar]
  11. GOLDTHWAIT D. A., GREENBERG G. R., PEABODY R. A. On the mechanism of synthesis of glycinamide ribotide and its formyl derivative. J Biol Chem. 1956 Aug;221(2):569–577. [PubMed] [Google Scholar]
  12. GUTMAN A. B., YUE T. F. AN ABNORMALITY OF GLUTAMINE METABOLISM IN PRIMARY GOUT. Am J Med. 1963 Dec;35:820–831. doi: 10.1016/0002-9343(63)90244-4. [DOI] [PubMed] [Google Scholar]
  13. GUTMAN A. B., YUE T. F. URINARY AMMONIUM EXCRETION IN PRIMARY GOUT. J Clin Invest. 1965 Sep;44:1474–1481. doi: 10.1172/JCI105254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GUTMAN A. B., YU F. T., ADLER M., JAVITT N. B. Intramolecular distribution of uric acid-N15 after administration of glycine-N15 and ammonium-N15 chloride to goury and non-goury subjects. J Clin Invest. 1962 Mar;41:623–636. doi: 10.1172/JCI104518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. GUTMAN A. B., YU T. F., BLACK H., YALOW R. S., BERSON S. A. Incorporation of glycine-1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects. Am J Med. 1958 Dec;25(6):917–932. doi: 10.1016/0002-9343(58)90063-9. [DOI] [PubMed] [Google Scholar]
  16. GUTMAN A. B., YU T. F. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med. 1957 Oct;23(4):600–622. doi: 10.1016/0002-9343(57)90231-0. [DOI] [PubMed] [Google Scholar]
  17. HARTMAN S. C., BUCHANAN J. M. Biosynthesis of the purines. XXI. 5-Phosphoribosylpyrophosphate amidotransferase. J Biol Chem. 1958 Aug;233(2):451–455. [PubMed] [Google Scholar]
  18. HENDERSON J. F. DUAL EFFECTS OF AMMONIUM CHLORIDE ON PURINE BIOSYNTHESIS DE NOVO IN EHRLICH ASCITES-TUMOR CELLS IN VITRO. Biochim Biophys Acta. 1963 Oct 15;76:173–180. [PubMed] [Google Scholar]
  19. HENDERSON J. F., KHOO M. K. SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM GLUCOSE IN EHRLICH ASCITES TUMOR CELLS IN VITRO. J Biol Chem. 1965 Jun;240:2349–2357. [PubMed] [Google Scholar]
  20. HERSCOVICS A., JOHNSTONE R. M. (14-C)FORMATE UTILIZATION IN CELL-FREE EXTRACTS OF EHRLICH ASCITES CELLS. Biochim Biophys Acta. 1964 Nov 8;93:251–263. doi: 10.1016/0304-4165(64)90373-3. [DOI] [PubMed] [Google Scholar]
  21. HOWELL R. R., ASHTON D. M., WYNGAARDEN J. B. Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities. Pediatrics. 1962 Apr;29:553–565. [PubMed] [Google Scholar]
  22. HOWELL R. R., SPEAS M., WYNGAARDEN J. B. A quantitative study of recycling of isotope from glycine-1-C14, alpha-N15 into various subunits of the uric acid molecule in a normal subject. J Clin Invest. 1961 Nov;40:2076–2082. doi: 10.1172/JCI104433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Henderson J. F., Brox L. W., Kelley W. N., Rosenbloom F. M., Seegmiller J. E. Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem. 1968 May 25;243(10):2514–2522. [PubMed] [Google Scholar]
  24. Henderson J. F., Rosenbloom F. M., Kelley W. N., Seegmiller J. E. Variations in purine metabolism of cultured skin fibroblasts from patients with gout. J Clin Invest. 1968 Jul;47(7):1511–1516. doi: 10.1172/JCI105844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hershko A., Hershko C., Mager J. Increased formation of 5-phosphoriboxyl-1-pyrophosphate in red blood cells of some gouty patients. Isr J Med Sci. 1968 Sep-Oct;4(5):939–944. [PubMed] [Google Scholar]
  26. Holmes E. W., McDonald J. A., McCord J. M., Wyngaarden J. B., Kelley W. N. Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J Biol Chem. 1973 Jan 10;248(1):144–150. [PubMed] [Google Scholar]
  27. JONES O. W., Jr, ASHTON D. M., WYNGAARDEN J. B. Accelerated turnover of phosphoribosylpyrophosphate, a purine nucleotide precursor, in certain gouty subjects. J Clin Invest. 1962 Sep;41:1805–1815. doi: 10.1172/JCI104638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. KENNAN A. L. Glutamine synthesis in rats with diabetic acidosis. Endocrinology. 1962 Aug;71:203–208. doi: 10.1210/endo-71-2-203. [DOI] [PubMed] [Google Scholar]
  29. Kelley W. N., Fox I. H., Wyngaarden J. B. Regulation of purine biosynthesis in cultured human cells. I. Effects of orotic acid. Biochim Biophys Acta. 1970 Sep 22;215(3):512–516. doi: 10.1016/0304-4165(70)90101-7. [DOI] [PubMed] [Google Scholar]
  30. Kelley W. N., Greene M. L., Rosenbloom F. M., Henderson J. F., Seegmiller J. E. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Intern Med. 1969 Jan;70(1):155–206. doi: 10.7326/0003-4819-70-1-155. [DOI] [PubMed] [Google Scholar]
  31. Kelley W. N., Rosenbloom F. M., Henderson J. F., Seegmiller J. E. A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci U S A. 1967 Jun;57(6):1735–1739. doi: 10.1073/pnas.57.6.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kelley W. N., Rosenbloom F. M., Seegmiller J. E., Howell R. R. Excessive production of uric acid in type I glycogen storage disease. J Pediatr. 1968 Apr;72(4):488–496. doi: 10.1016/s0022-3476(68)80339-7. [DOI] [PubMed] [Google Scholar]
  33. Kelley W. N., Rosenbloom F. M., Seegmiller J. E. The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism. J Clin Invest. 1967 Sep;46(9):1518–1529. doi: 10.1172/JCI105643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. LESCH M., NYHAN W. L. A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. Am J Med. 1964 Apr;36:561–570. doi: 10.1016/0002-9343(64)90104-4. [DOI] [PubMed] [Google Scholar]
  35. LEVENBERG B., HARTMAN S. C., BUCHANAN J. M. Biosynthesis of the purines. X. Further studies in vitro on the metabolic origin of nitrogen atoms 1 and 3 of the purine ring. J Biol Chem. 1956 May;220(1):379–390. [PubMed] [Google Scholar]
  36. Le Gal M. L., Le Gal Y., Roche J., Hedegaard J. Purine biosynthesis: enzymatic formation of ribosylamine-5-phosphate from ribose-5-phosphate and ammonia. Biochem Biophys Res Commun. 1967 Jun 23;27(6):618–624. doi: 10.1016/s0006-291x(67)80079-2. [DOI] [PubMed] [Google Scholar]
  37. Long W. K. Glutathione reductase in red blood cells: variant associated with gout. Science. 1967 Feb 10;155(3763):712–713. doi: 10.1126/science.155.3763.712. [DOI] [PubMed] [Google Scholar]
  38. MEISTER A., UDENFRIEND S., BESSMAN S. P. Diminished phenylketonuria in phenylpyruvic oligophrenia after administration of L-glutamine, L-glutamate or L-asparagine. J Clin Invest. 1956 Jun;35(6):619–626. doi: 10.1172/JCI103317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. MOLDAVE K., MEISTER A. Enzymic acylation of glutamine by phenylacetic acid. Biochim Biophys Acta. 1957 Jun;24(3):654–655. doi: 10.1016/0006-3002(57)90269-x. [DOI] [PubMed] [Google Scholar]
  40. MOLDAVE K., MEISTER A. Synthesis of phenylacetylglutamine by human tissue. J Biol Chem. 1957 Nov;229(1):463–476. [PubMed] [Google Scholar]
  41. Mizobuchi K., Buchanan J. M. Biosynthesis of the purines. XXIX. Purification and properties of formylglycinamide ribonucleotide amidotransferase from chicken liver. J Biol Chem. 1968 Sep 25;243(18):4842–4852. [PubMed] [Google Scholar]
  42. Motokawa Y., Kikuchi G. Glycine metabolism by rat liver mitochondria. IV. Isolation and characterization of hydrogen carrier protein, an essential factor for glycine metabolism. Arch Biochem Biophys. 1969 Dec;135(1):402–409. doi: 10.1016/0003-9861(69)90556-6. [DOI] [PubMed] [Google Scholar]
  43. NEIMS A. H., HELLERMAN L. Specificity of the D-amino acid oxidase in relation to glycine oxidase activity. J Biol Chem. 1962 Mar;237:PC976–PC978. [PubMed] [Google Scholar]
  44. NIERLICH D. P., MAGASANIK B. PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE OF AEROBACTER AEROGENES. PURIFICATION AND PROPERTIES, AND NONENZYMATIC FORMATION OF ITS SUBSTRATE 5'-PHOSPHORIBOSYLAMINE. J Biol Chem. 1965 Jan;240:366–374. [PubMed] [Google Scholar]
  45. OWEN E. E., ROBINSON R. R. Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride. J Clin Invest. 1963 Feb;42:263–276. doi: 10.1172/JCI104713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. PITTS R. F., PILKINGTON L. A., DEHAAS J. C. N15 TRACER STUDIES ON THE ORIGIN OF URINARY AMMONIA IN THE ACIDOTIC DOG, WITH NOTES ON THE ENZYMATIC SYNTHESIS OF LABELED CLUTAMIC ACID AND GLUTAMINES. J Clin Invest. 1965 May;44:731–745. doi: 10.1172/JCI105186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. PITTS R. F. RENAL PRODUCTION AND EXCRETION OF AMMONIA. Am J Med. 1964 May;36:720–742. doi: 10.1016/0002-9343(64)90182-2. [DOI] [PubMed] [Google Scholar]
  48. Pagliara A. S., Goodman A. D. Elevation of plasma glutamate in gout. Its possible role in the pathogenesis of hyperuricemia. N Engl J Med. 1969 Oct 2;281(14):767–770. doi: 10.1056/NEJM196910022811405. [DOI] [PubMed] [Google Scholar]
  49. Pitts R. F., Stone W. J. Renal metabolism of alanine. J Clin Invest. 1967 Apr;46(4):530–538. doi: 10.1172/JCI105554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Pollak V. E., Mattenheimer H. Glutaminase activity in the kidney in gout. J Lab Clin Med. 1965 Oct;66(4):564–570. [PubMed] [Google Scholar]
  51. Reem G. H. De novo purine biosynthesis by two pathways in Burkitt lymphoma cells and in human spleen. J Clin Invest. 1972 May;51(5):1058–1062. doi: 10.1172/JCI106897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Reem G. H. Enzymatic synthesis of 5'-phosphoribosylamine from ribose 5-phosphate and ammonia, an alternate first step in purine biosynthesis. J Biol Chem. 1968 Nov 10;243(21):5695–5701. [PubMed] [Google Scholar]
  53. SEEGMILLER J. E., GRAYZEL A. I., LASTER L., LIDDLE L. Uric acid production in gout. J Clin Invest. 1961 Jul;40:1304–1314. doi: 10.1172/JCI104360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. SEGAL S., WYNGAARDEN J. B. Plasma glutamine and oxypurine content in patients with gout. Proc Soc Exp Biol Med. 1955 Mar;88(3):342–345. doi: 10.3181/00379727-88-21583. [DOI] [PubMed] [Google Scholar]
  55. SONNE J. C., LIN I., BUCHANAN J. M. Biosynthesis of the purines. IX. Precursors of the nitrogen atoms of the purine ring. J Biol Chem. 1956 May;220(1):369–378. [PubMed] [Google Scholar]
  56. SONNE J. C., LIN I., BUCHANAN J. M. Biosynthesis of the purines. IX. Precursors of the nitrogen atoms of the purine ring. J Biol Chem. 1956 May;220(1):369–378. [PubMed] [Google Scholar]
  57. STEIN W. H. A chromatographic investigation of the amino acid constituents of normal urine. J Biol Chem. 1953 Mar;201(1):45–58. [PubMed] [Google Scholar]
  58. Seegmiller J. E., Klinenberg J. R., Miller J., Watts R. W. Suppression of glycine-15N incorporation into urinary uric acid by adenine-8-13C in normal and gouty subjects. J Clin Invest. 1968 May;47(5):1193–1203. doi: 10.1172/JCI105808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sperling O., Boer P., Persky-Brosh S., Kanarek E., De Vries A. Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):703–706. [PubMed] [Google Scholar]
  60. Sperling O., Eilam G., Sara-Persky-Brosh, De Vries A. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout. Biochem Med. 1972 Aug;6(4):310–316. doi: 10.1016/0006-2944(72)90017-8. [DOI] [PubMed] [Google Scholar]
  61. Sperling O., Eilam G., Sara-Persky-Brosh, De Vries A. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout. Biochem Med. 1972 Aug;6(4):310–316. doi: 10.1016/0006-2944(72)90017-8. [DOI] [PubMed] [Google Scholar]
  62. Sperling O., Frank M., Ophir R., Liberman U. A., Adam A., de Vries A. Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase associated with gout and uric acid lithiasis. Rev Eur Etud Clin Biol. 1970 Nov;15(9):942–947. [PubMed] [Google Scholar]
  63. Sperling O., Ophir R., de Vries A. Purine base incorporation into erythrocyte nucleotides and erythrocyte phosphoribosyltransferase activity in primary gout. Rev Eur Etud Clin Biol. 1971 Feb;16(2):147–151. [PubMed] [Google Scholar]
  64. Stone W. J., Balagura S., Pitts R. F. Diffusion equilibrium for ammonia in the kidney of the acidotic dog. J Clin Invest. 1967 Oct;46(10):1603–1608. doi: 10.1172/JCI105652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. WATTS R. W., CRAWHALL J. C. The first glycine metabolic pool in man. Biochem J. 1959 Oct;73:277–286. doi: 10.1042/bj0730277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. WYNGAARDEN J. B., GREENLAND R. A. The inhibition of succinoadenylate kinosynthetase of Escherichia coli by adenosine and guanosine 5'-monophosphates. J Biol Chem. 1963 Mar;238:1054–1057. [PubMed] [Google Scholar]
  67. WYNGAARDEN J. B., SILBERMAN H. R., SADLER J. H. Feedback mechanisms influencing purine ribotide synthesis. Ann N Y Acad Sci. 1958 Oct 13;75(1):45–60. doi: 10.1111/j.1749-6632.1958.tb36850.x. [DOI] [PubMed] [Google Scholar]
  68. WYNGAARDEN J. B., STETTEN D., Jr Uricolysis in normal man. J Biol Chem. 1953 Jul;203(1):9–21. [PubMed] [Google Scholar]
  69. Westby C. A., Gots J. S. Genetic blocks and unique features in the biosynthesis of 5'-phosphoribosyl-N-formylglycinamide in Salmonella typhimurium. J Biol Chem. 1969 Apr 25;244(8):2095–2102. [PubMed] [Google Scholar]
  70. Williamson D. H., Lopes-Vieira O., Walker B. Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses. Biochem J. 1967 Aug;104(2):497–502. doi: 10.1042/bj1040497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wood A. W., Seegmiller J. E. Properties of 5-phosphoribosyl-1-pyrophosphate amidotransferase from human lymphoblasts. J Biol Chem. 1973 Jan 10;248(1):138–143. [PubMed] [Google Scholar]
  72. Wyngaarden J. B. Glutamine phosphoribosylpyrophosphate amidotransferase. Curr Top Cell Regul. 1972;5:135–176. doi: 10.1016/b978-0-12-152805-8.50011-3. [DOI] [PubMed] [Google Scholar]
  73. Yü T. F., Adler M., Bobrow E., Gutman A. B. Plasma and urinary amino acids in primary gout, with special reference to glutamine. J Clin Invest. 1969 May;48(5):885–894. doi: 10.1172/JCI106047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Yü T. F., Balis M. E., Krenitsky T. A., Dancis J., Silvers D. N., Elion G. B., Gutman A. B. Rarity of X-linked partial hypoxanthine-guanine phosphoribosyltransferase deficiency in a large gouty population. Ann Intern Med. 1972 Feb;76(2):255–264. doi: 10.7326/0003-4819-76-2-255. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES